6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K/A: Report of foreign private issuer (related to financial reporting)
20-F: Registration statement / Annual report / Transition report
6-K: Report of foreign private issuer (related to financial reporting)
SHL Telemedicine | 6-K: Report of foreign private issuer (related to financial reporting)
SHL Telemedicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SHL Telemedicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
SHL Telemedicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ido Nouberger(8.58%),Victor Shamrich(8.58%), etc.
SHL Telemedicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SHL Telemedicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SHL Telemedicine | 6-K: Report of foreign private issuer (related to financial reporting)
SHL Telemedicine | SC 13D: Statement of acquisition of beneficial ownership by individuals
SHL Telemedicine | SC 13D: Statement of acquisition of beneficial ownership by individuals-Ido Nouberger(8.58%),Victor Shamrich(8.58%), etc.
SHL Telemedicine | 6-K/A: Report of foreign private issuer (related to financial reporting)
SHL Telemedicine | 6-K: Report of foreign private issuer (related to financial reporting)
SHL Telemedicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SHL Telemedicine | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORD | 6-K: Report of foreign private issuer (related to financial reporting)
SHL TELEMEDICINE LIMITED SPON ADS EACH REP 1 ORD | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
SHL Telemedicine | 20-F: FY2022 Annual Report
No Data